Audience: Individuals with Tourette Syndrome or another Tic Disorder, families and caregivers, researchers, clinicians, and other community members
About the Science in Action Showcase: The Science in Action Showcase is a webinar series designed to provide up to date information on important scientific, clinical, and technological advancements shaping Tourette Syndrome research in 2026. Led by leading experts across neuroscience, behavioral therapy, neuromodulation, and pharmacology, this series turns complex science into digestible, engaging conversations. Participants will learn what’s new, what’s promising, and what’s on the horizon for improving care, treatment, and quality of life for those who experience tics.
Developing Wearable Median Nerve Stimulation for Tic Disorders
This session explores the development of wearable median nerve stimulation (MNS) as a promising intervention for Tic Disorders. Attendees will learn how MNS technology works, the scientific rationale behind targeting the median nerve, and what current research reveals for its impact on tic frequency and severity. The presentation will highlight recent engineering advances, clinical trial findings, and real-world considerations for translating this approach into an accessible, user-friendly wearable device. Participants will gain insight into the potential role of MNS within the broader treatment landscape and the future directions shaping this emerging therapeutic tool.
Key Takeaways:
- Understand how wearable MNS works and why the median nerve is targeted
- Learn what current research shows about MNS effects on tic frequency and severity
- Hear about the role of MNS in treatment options and where this technology is headed
Professor Stephen Jackson
Stephen Jackson is Professor of Cognitive Neuroscience and Director of the University of Nottingham’s Centre for Neuromodulation, Neurotechnology, and Neurotherapeutics.
His research focuses on using multimodal brain imaging and brain stimulation techniques to investigate human sensorimotor function in health and disorder. He uses state-of-the-art MR imaging, MR spectroscopy, magnetoencephalography and non-invasive brain stimulation techniques to investigate the pathophysiology of common brain health conditions, with a particular focus on movement disorders. His recent research interests have centered on understanding the neural basis for Tic Disorders, and in developing novel therapeutic approaches for movement disorders such as Tourette Syndrome and Parkinson’s disease, based on the use of wearable technology for delivering non-invasive brain stimulation.
Stephen is a Founder and Chief Scientific Officer of Neurotherapeutics Ltd, a University of Nottingham spin out to develop and translate a wearable Neupulse medical device for treatment of movement disorders which was recommended by NICE in 2024 for use by NHS patients in the UK. The research underpinning Neupulse was awarded the Times Higher Education’s STEM project of the year in 2023.
Stephen’s research is funded by the following: the UK Medical Research Council (MRC); the UK Engineering & Physical Science Research Council (EPSRC); the UK National Institute for Health Research (NIHR); Tourettes Action UK, and Parkinson’s UK.
